The Commission presents a proposal to enhance the control of drug precursors, the chemical substances that are used by both legitimate industries and in the production of illicit drugs. As Europe’s drug market evolves, the proposal strengthens authorities to respond to emerging drugs and production processes.
Rengiamos (updated on 16/12/2025) - Bureau decision date: 02/12/2025
This initiative aims to simplify EU legislation on medical devices and diagnostics to enhance competitiveness, foster innovation and ensure proportionate, cost-effective safety requirements while maintaining high levels of patient protection and public health.
Rengiamos (updated on 17/12/2025) - Bureau decision date: 02/12/2025
